vs
Astrana Health, Inc.（ASTH）与Bowman Consulting Group Ltd.（BWMN）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Bowman Consulting Group Ltd.的7.4倍（$950.5M vs $129.0M）。Bowman Consulting Group Ltd.净利率更高（1.5% vs 0.7%，领先0.8%）。Astrana Health, Inc.同比增速更快（42.9% vs 13.9%）。Bowman Consulting Group Ltd.自由现金流更多（$8.1M vs $-6.0M）。过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 16.6%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
SLR咨询是一家私有的国际可持续发展咨询企业，在欧洲、北美洲、南美洲、大洋洲及非洲均设有办事处。公司以「推动可持续发展落地」为宗旨，凭借遍布全球的专业顾问与技术团队，携手客户共同应对全球最复杂的各类可持续发展挑战。
ASTH vs BWMN — 直观对比
营收规模更大
ASTH
是对方的7.4倍
$129.0M
营收增速更快
ASTH
高出29.0%
13.9%
净利率更高
BWMN
高出0.8%
0.7%
自由现金流更多
BWMN
多$14.1M
$-6.0M
两年增速更快
ASTH
近两年复合增速
16.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $129.0M |
| 净利润 | $6.6M | $2.0M |
| 毛利率 | — | 55.0% |
| 营业利润率 | 1.9% | 3.2% |
| 净利率 | 0.7% | 1.5% |
| 营收同比 | 42.9% | 13.9% |
| 净利润同比 | 184.4% | -66.7% |
| 每股收益（稀释后） | $0.12 | $0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHBWMN
| Q4 25 | $950.5M | $129.0M | ||
| Q3 25 | $956.0M | $126.0M | ||
| Q2 25 | $654.8M | $122.1M | ||
| Q1 25 | $620.4M | $112.9M | ||
| Q4 24 | $665.2M | $113.2M | ||
| Q3 24 | $478.7M | $113.9M | ||
| Q2 24 | $486.3M | $104.5M | ||
| Q1 24 | $404.4M | $94.9M |
净利润ASTHBWMN
| Q4 25 | $6.6M | $2.0M | ||
| Q3 25 | $373.0K | $6.6M | ||
| Q2 25 | $9.4M | $6.0M | ||
| Q1 25 | $6.7M | $-1.7M | ||
| Q4 24 | $-7.8M | $5.9M | ||
| Q3 24 | $16.1M | $771.0K | ||
| Q2 24 | $19.2M | $-2.1M | ||
| Q1 24 | $14.8M | $-1.6M |
毛利率ASTHBWMN
| Q4 25 | — | 55.0% | ||
| Q3 25 | — | 53.1% | ||
| Q2 25 | — | 53.7% | ||
| Q1 25 | — | 51.4% | ||
| Q4 24 | — | 53.2% | ||
| Q3 24 | — | 52.4% | ||
| Q2 24 | — | 52.5% | ||
| Q1 24 | — | 50.6% |
营业利润率ASTHBWMN
| Q4 25 | 1.9% | 3.2% | ||
| Q3 25 | 2.0% | 4.2% | ||
| Q2 25 | 3.1% | 7.4% | ||
| Q1 25 | 3.3% | 1.0% | ||
| Q4 24 | 0.1% | 1.2% | ||
| Q3 24 | 5.9% | 0.4% | ||
| Q2 24 | 6.2% | -1.2% | ||
| Q1 24 | 7.5% | -2.8% |
净利率ASTHBWMN
| Q4 25 | 0.7% | 1.5% | ||
| Q3 25 | 0.0% | 5.3% | ||
| Q2 25 | 1.4% | 4.9% | ||
| Q1 25 | 1.1% | -1.5% | ||
| Q4 24 | -1.2% | 5.2% | ||
| Q3 24 | 3.4% | 0.7% | ||
| Q2 24 | 3.9% | -2.0% | ||
| Q1 24 | 3.7% | -1.6% |
每股收益（稀释后）ASTHBWMN
| Q4 25 | $0.12 | $0.13 | ||
| Q3 25 | $0.01 | $0.37 | ||
| Q2 25 | $0.19 | $0.34 | ||
| Q1 25 | $0.14 | $-0.11 | ||
| Q4 24 | $-0.14 | $0.37 | ||
| Q3 24 | $0.33 | $0.04 | ||
| Q2 24 | $0.40 | $-0.13 | ||
| Q1 24 | $0.31 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $11.1M |
| 总债务越低越好 | — | $57.6M |
| 股东权益账面价值 | $779.3M | $261.1M |
| 总资产 | $2.2B | $579.7M |
| 负债/权益比越低杠杆越低 | — | 0.22× |
8季度趋势，按日历期对齐
现金及短期投资ASTHBWMN
| Q4 25 | $429.5M | $11.1M | ||
| Q3 25 | $463.4M | $16.2M | ||
| Q2 25 | $342.1M | $15.5M | ||
| Q1 25 | $260.9M | $10.7M | ||
| Q4 24 | $290.8M | $6.7M | ||
| Q3 24 | $350.3M | $11.7M | ||
| Q2 24 | $327.7M | $23.1M | ||
| Q1 24 | $337.3M | $11.7M |
总债务ASTHBWMN
| Q4 25 | — | $57.6M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $32.0M | ||
| Q1 25 | — | $36.4M | ||
| Q4 24 | — | $38.1M | ||
| Q3 24 | — | $36.4M | ||
| Q2 24 | — | $38.8M | ||
| Q1 24 | — | $26.8M |
股东权益ASTHBWMN
| Q4 25 | $779.3M | $261.1M | ||
| Q3 25 | $775.5M | $261.8M | ||
| Q2 25 | $765.5M | $249.6M | ||
| Q1 25 | $745.4M | $244.1M | ||
| Q4 24 | $712.7M | $246.1M | ||
| Q3 24 | $704.6M | $243.2M | ||
| Q2 24 | $678.9M | $235.6M | ||
| Q1 24 | $653.5M | $167.3M |
总资产ASTHBWMN
| Q4 25 | $2.2B | $579.7M | ||
| Q3 25 | $2.2B | $510.2M | ||
| Q2 25 | $1.4B | $538.2M | ||
| Q1 25 | $1.3B | $528.7M | ||
| Q4 24 | $1.4B | $505.9M | ||
| Q3 24 | $1.3B | $497.0M | ||
| Q2 24 | $1.3B | $463.4M | ||
| Q1 24 | $1.2B | $420.5M |
负债/权益比ASTHBWMN
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.11× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $9.4M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $8.1M |
| 自由现金流率自由现金流/营收 | -0.6% | 6.3% |
| 资本支出强度资本支出/营收 | 0.3% | 0.9% |
| 现金转化率经营现金流/净利润 | -0.44× | 4.76× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $33.4M |
8季度趋势，按日历期对齐
经营现金流ASTHBWMN
| Q4 25 | $-2.9M | $9.4M | ||
| Q3 25 | $10.0M | $10.2M | ||
| Q2 25 | $90.9M | $4.3M | ||
| Q1 25 | $16.6M | $12.0M | ||
| Q4 24 | $-10.9M | $11.9M | ||
| Q3 24 | $34.0M | $6.8M | ||
| Q2 24 | $23.2M | $3.1M | ||
| Q1 24 | $6.0M | $2.5M |
自由现金流ASTHBWMN
| Q4 25 | $-6.0M | $8.1M | ||
| Q3 25 | $7.4M | $10.1M | ||
| Q2 25 | $89.5M | $4.2M | ||
| Q1 25 | $13.6M | $11.0M | ||
| Q4 24 | $-13.5M | $11.7M | ||
| Q3 24 | $31.7M | $6.6M | ||
| Q2 24 | $20.4M | $2.7M | ||
| Q1 24 | $5.6M | $2.3M |
自由现金流率ASTHBWMN
| Q4 25 | -0.6% | 6.3% | ||
| Q3 25 | 0.8% | 8.0% | ||
| Q2 25 | 13.7% | 3.4% | ||
| Q1 25 | 2.2% | 9.7% | ||
| Q4 24 | -2.0% | 10.4% | ||
| Q3 24 | 6.6% | 5.8% | ||
| Q2 24 | 4.2% | 2.6% | ||
| Q1 24 | 1.4% | 2.4% |
资本支出强度ASTHBWMN
| Q4 25 | 0.3% | 0.9% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.2% | 0.1% | ||
| Q1 25 | 0.5% | 0.9% | ||
| Q4 24 | 0.4% | 0.2% | ||
| Q3 24 | 0.5% | 0.2% | ||
| Q2 24 | 0.6% | 0.3% | ||
| Q1 24 | 0.1% | 0.3% |
现金转化率ASTHBWMN
| Q4 25 | -0.44× | 4.76× | ||
| Q3 25 | 26.69× | 1.54× | ||
| Q2 25 | 9.65× | 0.71× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | 2.02× | ||
| Q3 24 | 2.11× | 8.81× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BWMN
暂无分部数据
